The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
A roundup of the latest expansions and investments from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring news from Lonza, Noramco, Schott, Almac, and PCI Pharma...
A roundup of the latest expansions and investments from suppliers, contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs), featuring news from Catalent Pharma Solutions, Brammer Bio, APC,...
Cambrex, a contract manufacturing organization of small-molecule active pharmaceutical ingredients (APIs), and AGC Biologics, a Bothell, Washington-based contract development and manufacturing organization of biologics, have announced plans to...
PMI BioPharma Solutions (PMI Bio), a new contract development and manufacturing organization formed in January of 2018, has established research and manufacturing operations at multiple sites located in Nashville and Celina, Tennessee. The sites...
MilliporeSigma has opened a new $20-million 3,800-square-meter laboratory in Singapore for biologic testing services. The new lab complex involves the company’s BioReliance biosafety testing services as well as its M Lab Collaboration Center, which...
Lonza has invested CHF 400 million ($414 million) to add two new biomanufacturing services (Ibex Design and Ibex Develop) as part of its Ibex Solutions package from the company’s 100,000-square meter biopark in Visp, Switzerland.
Lonza’s first...
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, plans to establish a new process development and manufacturing facility at its facility in Chiba, Japan. This move is part of the...
Evonik, a specialty and fine chemical producer, has completed a EUR 36-million ($42-million) expansion of its contract manufacturing capabilities in the US and Europe. A series of technologies, including high-potency active pharmaceutical...
Wacker, a Munich, Germany-based chemical company, has expanded its biologics production facilities in Jena, Germany, with a new microbiology laboratory and equipment for process and product characterization.
“In recent years, we have been...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has completed its acquisition of Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, for approximately...
PCI Pharma Services (PCI) has agreed to acquire Sherpa Clinical Packaging (Sherpa), a San Diego, California-based provider of clinical-trial supply services. The addition of Sherpa’s capabilities enables PCI to support customers from early phases...
Avara Pharmaceutical Services, a Norwalk, Connecticut-headquartered contract development and manufacturing organization, has acquired Sandoz’s sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of...
Thermo Fisher Scientific has agreed to acquire the advanced bioprocessing business of Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company.
The bioprocessing business combines a technical services...
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego.
The...
Olon S.p.A., an Italy-headquartered contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and a generics supplier, has acquired a local generics chemical operations API manufacturing facility in Mahad,...
